ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 110 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $43,217 | -54.3% | 18,790 | -39.8% | 0.00% | -50.0% |
| Q1 2023 | $94,533 | +1.1% | 31,199 | -22.3% | 0.01% | +20.0% |
| Q4 2022 | $93,547 | -9.2% | 40,149 | -25.5% | 0.01% | +25.0% |
| Q3 2022 | $103,000 | -44.6% | 53,877 | -21.4% | 0.00% | -20.0% |
| Q2 2022 | $186,000 | +5.1% | 68,565 | +15.2% | 0.01% | 0.0% |
| Q1 2022 | $177,000 | +2.9% | 59,500 | +34.3% | 0.01% | +25.0% |
| Q4 2021 | $172,000 | +3.0% | 44,300 | +13.6% | 0.00% | 0.0% |
| Q3 2021 | $167,000 | -48.0% | 39,000 | -56.9% | 0.00% | -50.0% |
| Q4 2020 | $321,000 | +13.8% | 90,400 | +0.4% | 0.01% | -42.9% |
| Q3 2020 | $282,000 | +1242.9% | 90,000 | +2547.1% | 0.01% | +600.0% |
| Q3 2017 | $21,000 | – | 3,400 | +3300.0% | 0.00% | – |
| Q2 2016 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |